Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells
Authors
Tanja Mesti
Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou, paris, France
Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Nadia Bouchemal
CSPBAT, UMR 7244, CNRS, Université Paris 13, Bobigny, France
Claire Banissi
Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou, paris, France
Mohamed N. Triba
CSPBAT, UMR 7244, CNRS, Université Paris 13, Bobigny, France
Carole Marbeuf-Gueye
CSPBAT, UMR 7244, CNRS, Université Paris 13, Bobigny, France
Maja Cemazar
Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Laurence Le Moyec
Unité de Biologie Intégrative des Adaptations à l’Exercice, Université d’Evry, Evry, France
Antoine F. Carpentier
Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou, paris, France
Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Service de Neurologie, Bobigny, France
Philippe Savarin
Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Janja Ocvirk
Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 392 - 398
Submitted on: Nov 30, 2017
Accepted on: Oct 21, 2018
Published on: Nov 26, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2018 Tanja Mesti, Nadia Bouchemal, Claire Banissi, Mohamed N. Triba, Carole Marbeuf-Gueye, Maja Cemazar, Laurence Le Moyec, Antoine F. Carpentier, Philippe Savarin, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.